UY39705A - Novedosos compuestos útiles como agonistas de sting y sus usos - Google Patents

Novedosos compuestos útiles como agonistas de sting y sus usos

Info

Publication number
UY39705A
UY39705A UY0001039705A UY39705A UY39705A UY 39705 A UY39705 A UY 39705A UY 0001039705 A UY0001039705 A UY 0001039705A UY 39705 A UY39705 A UY 39705A UY 39705 A UY39705 A UY 39705A
Authority
UY
Uruguay
Prior art keywords
novel compounds
compounds useful
sting agonists
compounds
sting
Prior art date
Application number
UY0001039705A
Other languages
English (en)
Inventor
Wei Long
Yanping Wang
Yang Ye
Xiuwei Li
Guiqun Yang
Fashun Yan
Original Assignee
Jacobio Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobio Pharmaceuticals Co Ltd filed Critical Jacobio Pharmaceuticals Co Ltd
Publication of UY39705A publication Critical patent/UY39705A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se proporcionan compuestos de la Fórmula general I, II, III, IV, V y sus sales farmacéuticamente aceptables, que pueden ser útiles como inductores de la producción de interferón tipo I, específicamente como agentes activos de STING. También se proporcionan síntesis, composiciones y usos de dichos compuestos.
UY0001039705A 2021-03-30 2022-03-29 Novedosos compuestos útiles como agonistas de sting y sus usos UY39705A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CN2021083783 2021-03-30
CN2021090945 2021-04-29
CN2021111479 2021-08-09
CN2021128942 2021-11-05
CN2021130097 2021-11-11
CN2021138806 2021-12-16
CN2021143043 2021-12-30
CN2022071548 2022-01-12

Publications (1)

Publication Number Publication Date
UY39705A true UY39705A (es) 2022-10-31

Family

ID=83457956

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039705A UY39705A (es) 2021-03-30 2022-03-29 Novedosos compuestos útiles como agonistas de sting y sus usos

Country Status (8)

Country Link
US (1) US20240116909A1 (es)
EP (1) EP4313962A1 (es)
JP (1) JP2024511832A (es)
CN (1) CN117203194A (es)
AR (1) AR125608A1 (es)
TW (1) TW202302579A (es)
UY (1) UY39705A (es)
WO (1) WO2022206725A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202342105A (zh) * 2021-12-17 2023-11-01 大陸商北京加科思新藥研發有限公司 包含可用作sting激動劑的化合物的化合物-連接基構建體及其用途
WO2024032782A1 (en) * 2022-08-12 2024-02-15 Jacobio Pharmaceuticals Co.Ltd. Vaccine adjuvants and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3095646A1 (en) * 2018-04-03 2019-10-10 Merck Sharp & Dohme Corp. Benzothiophenes and related compounds as sting agonists
WO2019195063A1 (en) * 2018-04-03 2019-10-10 Merck Sharp & Dohme Corp. Aza-benzothiophene compounds as sting agonists
CA3147397A1 (en) * 2019-07-22 2021-01-28 Lupin Limited Macrocyclic compounds as sting agonists and methods and uses thereof

Also Published As

Publication number Publication date
TW202302579A (zh) 2023-01-16
WO2022206725A1 (en) 2022-10-06
AR125608A1 (es) 2023-08-02
JP2024511832A (ja) 2024-03-15
EP4313962A1 (en) 2024-02-07
US20240116909A1 (en) 2024-04-11
CN117203194A (zh) 2023-12-08

Similar Documents

Publication Publication Date Title
NI201900029A (es) COMPUESTOS DE BENZO[b]TIOFENO COMO AGONISTAS DE STING
UY39705A (es) Novedosos compuestos útiles como agonistas de sting y sus usos
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
UY39694A (es) Novedosos compuestos útiles como agonistas de sting y sus usos
UY38448A (es) Compuestos de azol-amida pesticidamente activos
BR112020020085A8 (pt) Composto, composição farmacêutica, e, métodos para induzir uma resposta imune, para induzir produção de interferons de tipo i dependentes de sting e para tratar um distúrbio de proliferação celular
UY38281A (es) Compuestos de azol-amida pesticidamente activos
CO2018000344A2 (es) Derivados de piperidina 1,4-sustituidos
CY1118735T1 (el) Παραγωγα βενζιμιδαζολο-προλινης
ECSP18024565A (es) Benzamidas sustituidas con isoxazolinas y análalogos como insecticidas
UY38651A (es) Compuestos de diazina-amida activos como pesticidas
CO6361936A2 (es) Imidazopiridazinacarbonitrilos utiles como inhibidores de quinasa
CR20150419A (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
CY1125004T1 (el) Ετεροαρυλο υποκατεστημενες βητα-υδροξυαιθυλαμινες για χρηση στη θεραπεια της υπεργλυκαιμιας
AR113958A1 (es) Macrociclos a como inhibidores de pde1
AR072510A1 (es) Derivados de triazinas y de uracilos, su preparacion y su aplicacion en terapeutica humana
CO6150181A2 (es) Compuesto 6-(bencilo sustituido con heterociclo)-4-oxoquinolina y su uso como inhibidor de integrasa vih
UY38809A (es) Derivados de 3,6-diamino-piridazin-3ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
UY36416A (es) 1-[2-(aminometil)bencil]-2-tioxo-1,2,3,5-tetrahidro-4h-pirrolo[3,2-d]pirimidin-4-onas como inhibidores de la mieloperoxidasa
ECSP22030481A (es) Compuestos de amina cíclica activos como plaguicidas
CL2021002480A1 (es) Agonistas compuestos macrocíclicos como de sting
AR100821A1 (es) Pirazolil-triazolil-piridinas como agentes plaguicidas
CO2023017151A2 (es) Inhibidores de ripk1 de nicotinamida
ECSP23070418A (es) Moduladores de sting (estimulador de genes de interferón)
AR052365A1 (es) Derivados antihelminticos de imidazol-tiazol